LINK:  https://bswhealth.webex.com/bswhealth/j.php?MTID=mc9315024f9bc84392f9e8dd3a6e90b4f

OBJECTIVES: Upon completion of this activity, the participant should be able to:  (1) Describe current practice guidelines for patients with resolved hepatitis B who are to be placed on immunosuppressive drug therapy. (2) Analyze whether there may be alternate ways of preventing HBsAg recurrence after OLT or de novo hepatitis B following receipt of an anti-HBc-positive liver other than long term or indefinite antiviral prophylaxis. (3)Evaluate the immunogenicity and safety of an FDA licensed HBV vaccine that has been shown to be more immunogenic hepatitis B vaccine (hep B CpG) than traditional recombinant vaccines in patients requiring biologic ISDT for chronic inflammatory disease and those taking calcineurin inhibitor and mycophenolate post liver transplantation for hepatitis B. (4) Discuss that antibody responses to hep B CpG vaccine appear to differ according to the potency of the immunosuppressive regimen.  

FACULTY DISCLOSURE: Robert Perrillo, MD, was on the Supply FDA licensed vaccine for study participants and partial funding for clinical research coordinator for the speakers’ bureau for Dynavax Technologies Company.

PLANNER DISCLOSURE: James Trotter, MD, Sumeet Asrani, MD, Gregory McKenna, MD, and Kathy Brown, RN, CCTC, have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CEPTC Credit: The American Board for Transplant Certification (ABTC) has been applied for educational offering for up to 1 Category 1 Continuing Education Point for Transplant Certification (CEPTCs).

For information, please contact Karina Pena at karina.pena@bswhealth.org